How can Washington and the private sector work together to manage the cost of health care and deliver value to consumers?

The Economist Group will host a two-part morning discussion featuring policymakers and health care CEOs to examine the biggest cost drivers in the U.S. health care system. Part one will feature a Washington-oriented conversation taking a deep dive into legislative and regulatory solutions to combat rising health care costs.

Part two will feature health care industry CEOs discussing the evolution of the pharmaceutical business model and a reevaluation of priorities including production of personalized medicines, R&D, and care for chronic diseases.

Join The Economist Group on Wednesday, October 3, for a morning discussion during which policymakers and health care CEOs examine the biggest cost drivers in the U.S. health care system.

Join the conversation: @RollCall @PhRMA #LeadingOnValue

 Welcome Remarks
Jason Dick, Managing Editor, CQ Roll Call
Headliner Interview
Seema Verma, Administrator, Centers for Medicare & Medicaid Services
In conversation with Jason Dick, Managing Editor, CQ Roll Call
View from the Top: Industry Leaders
Olivier Brandicourt, CEO, Sanofi
Laurie Glimcher, President and CEO, Dana-Farber Cancer Institute
Redonda Miller, MD, President, Johns Hopkins Hospital
Michael Carson, President and CEO, Harvard Pilgrim Health Care
In conversation with Tom Easton, US Finance Editor, The Economist
Access to Progress: Ensuring Patients Benefit from Breakthrough Innovation (Sponsor Perspective)
Robert Bradway, Chairman and CEO, Amgen
In conversation with Leslie Norwalk, Former Acting Administrator, Centers for Medicare & Medicaid Services
Closing Remarks
Jason Dick, Managing Editor, CQ Roll Call
Sponsors Interview
Michael Ybarra, VP, PhRMA